A recombinant type IV collagen composition for repairing basement membrane and soothing and reducing redness

Through the combination of recombinant type IV collagen and repairing nonapeptide GAAGLPGPK, the damage problem of the basement membrane and endothelial barrier was solved, and the repair of the basement membrane and a significant reduction in skin redness was achieved, which improved the skin health level.

CN119925578BActive Publication Date: 2025-08-05XIAN GIANT BIOGENE TECH CO LTD
1 Cites 0 Cited by

Patent Information

Application Number
CN202510192782.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-02-20
Publication Date
2025-08-05
Estimated Expiration
2045-02-20

AI Technical Summary

Technical Problem

The prior art lacks efficient and targeted solutions to repair the basement membrane barrier and endothelial barrier, protect the skin from UV and oxidative stress damage, and sensitive skin problems have not been effectively alleviated.

Method used

Recombinant type IV collagen and repairing nonapeptide GAAGLPGPK are used to inhibit the phosphorylation of VE-cadherin protein, maintain the tight junction between endothelial cells, protect the endothelial barrier function, and achieve synergistic efficiency through combined use.

Benefits of technology

Significantly repair the basement membrane barrier, reduce redness and redness in the skin, improve skin health, and provide long-term soothing effects.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention provides a recombinant type IV collagen composition for repairing basement membrane and soothing and reducing redness. The inventors found that the recombinant type IV collagen described in the specification of this patent inhibits the phosphorylation of VE-cadherin protein by mediating the PKCα / PYK2 / Src signaling pathway, protects the tight junctions between endothelial cells, prevents the leakage of blood components, and reduces vascular permeability; it can also improve the dissociation of the VE-cadherin complex caused by oxidative stress and maintain the homeostasis of the endothelial barrier; therefore, it has good effects of repairing the basement membrane barrier and soothing and reducing redness. The inventors also first discovered that the repair peptide (GAAGLPGPK) has the effects of repairing the basement membrane barrier, soothing and reducing redness, and the combination of a certain proportion of the recombinant type IV collagen and the repair peptide shows synergistic effects in repairing the basement barrier and soothing and reducing redness.
Need to check novelty before this filing date? Find Prior Art